This study aimed to identify potential novel drug candidates and targets for Parkinson’s disease. First, 970 genes that have been reported to be related to PD were collected from five databases, and functional enrichment analysis of these genes was conducted to investigate their potential mechanisms. Then, we collected drugs and related targets from DrugBank, narrowed the list by proximity scores and Inverted Gene Set Enrichment analysis of drug targets, and identified potential drug candidates for PD treatment. Finally, we compared the expression distribution of the candidate drug-target genes between the PD group and the control group in the public dataset with the largest sample size (GSE99039) in Gene Expression Omnibus. Ten drugs with an FDR < 0.1 and their corresponding targets were identified. Some target genes of the ten drugs significantly overlapped with PD-related genes or already known therapeutic targets for PD. Nine differentially expressed drug-target genes with p < 0.05 were screened. This work will facilitate further research into the possible efficacy of new drugs for PD and will provide valuable clues for drug design.
To investigate whether the cornea nerve can distinguish between different subtypes of Parkinson's disease. A total of 63 patients diagnosed with Parkinson's disease—comprising tremor-dominant (TD), postural instability and gait disturbance (PIGD), and mixed subtypes—were included alongside 31 age- and gender-matched control participants. All participants underwent In vivo confocal microscopy (IVCM) examinations along with comprehensive assessments of clinical neurological symptoms using the Movement Disorders Society Unified Parkinson's Disease Rating Scale, Hoehn and Yahr stages, and Montreal Cognitive Assessment scores. The detection range of IVCM includes the indicators of central and inferior whorl-like cornea nerve. This study involved 63 patients, 23 were classified as having the TD type, 30 as having the PIGD type, and 10 as mixed type. Among them, most of central and whorl-like corneal nerve indicators were significantly lower in the PIGD group compared to the TD group. Receiver operating characteristic analysis demonstrated that combined central and inferior whorl-like corneal nerve indicators exhibited high discriminatory power between TD and PIGD types, with an area under the curve of 0.969. As a non-invasive examination method, IVCM holds significant value for differentiating Parkinson's disease subtypes and identifying patients with varying motor manifestations. Among these findings, individuals with PIGD displayed more pronounced corneal nerve damage; furthermore, patients exhibiting lower inferior whorl length, corneal nerve fiber width, and fractal dimension of corneal nerves values were found to be at greater risk of being classified within the PIGD subtype.